Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
US6969723B2 · kind B2 · utility
5Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 2002 |
| Grant date | Nov 29, 2005 |
| Priority date | — |
| Expiry date | May 29, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of general formula (I), wherein R4 and R5 stand for hydrogen atom or form together an 1,3-butadienyl group, optionally substituted by a methylenedioxy group or one or more straight or branched C1-4 alkyl group, straight or branched C1-4 alkoxy group, hydroxy group or halogen atom; are strong adenosine A3 receptor ligands preferably antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.